Table 3.
Concerns about 3D-printed drug products expressed by the healthcare professionals attending the focus group discussions.
Subcategory | Question or Comment (citations) |
---|---|
Medication safety | Is the drug substance evenly distributed within the printed dosage form? |
Does the printing technology produce accurate doses? | |
Does the printed dosage form perform in a desired manner and enable the optimum therapeutic effect? | |
Is it possible to check the content of each formulation with a barcode reader? | |
How are the different drug products identified if they look very similar? | |
How long is the shelf-life and can the medicine be stored in room temperature? | |
Drug administration | Can the printed dosage form be dissolved or dispersed and given through a nasogastric tube? |
For small children, it is essential that you can print a small sized dosage form. | |
If the printed drug products are big in size and do not dissolve/disperse in liquid, then it is not an answer to the needs of pediatric medication. | |
Production and delivery on-demand | How is the logistics at the wards affected if there are many patient-specific drug products instead of commercial packages? |
What is the delivery time? | |
How fast can the hospital pharmacy react to dose changes? | |
Costs | How much more expensive are patient-specific drug products? |
What are the costs? Is 3D printing profitable and sensible? | |
Does tailoring of doses give enough advantage that it is worth paying for? |